Rating History for ResMed (RMD) by Goldman Sachs

More Stocks Rated by Goldman Sachs | Latest Ratings for RMD
Date Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
4/26/2013 Upgrade Conviction Buy
(Buy)		 N/A
(N/A)		 45.52 50.07 10% Details
4/27/2012 Upgrade Buy
(N/A)		 N/A
(N/A)		 32.05 45.52 42.03% Details